By scavenging chemokines such as CCL2, it impairs the recruitment of key immune effectors like NK cells, thereby reducing tumor-killing activity and facilitating immune evasion.31 The impact of regulating ACKR2 varies depending on cancer type, stage, and the specific immune cells involved in the anti-tumor response. The gene discussed is ACKR2; the disease is cancer.